Christine Lu (@chrisluphd) 's Twitter Profile
Christine Lu

@chrisluphd

Associate Professor of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute

ID: 2331264152

calendar_today07-02-2014 04:07:11

245 Tweet

160 Followers

69 Following

Division of Health Policy and Insurance Research (@healthpolicydpm) 's Twitter Profile Photo

This week's #HPI #ResearchWednesday is a cross-sectional study by #HPI's Christine Lu that examines the knowledge and attitudes of clinical pharmacists on Pharmacogenetic testing in China. Read the whole article here: mdpi.com/2075-4426/12/8…

This week's #HPI #ResearchWednesday is a cross-sectional study by #HPI's <a href="/ChrisLuPhD/">Christine Lu</a> that examines the knowledge and attitudes of clinical pharmacists on Pharmacogenetic testing in China. Read the whole article here: mdpi.com/2075-4426/12/8…
PROMoTeR_DPM (@promoter_dpm) 's Twitter Profile Photo

New Article! "A Survey of Research Participants’ #Privacy- #Related #Experiences and Willingness to Share #Real- #World #Data with Researchers" Co authored by PROMoTeR_DPM Member, Christine Lu is published in JPM_MDPI buff.ly/3ASZg86

New Article! "A Survey of Research Participants’ #Privacy- #Related #Experiences and Willingness to Share #Real- #World #Data with Researchers" Co authored by <a href="/PROMoTeR_DPM/">PROMoTeR_DPM</a> Member, <a href="/ChrisLuPhD/">Christine Lu</a> is published in <a href="/JPM_MDPI/">JPM_MDPI</a> buff.ly/3ASZg86
Department of Population Medicine (@deptpopmed) 's Twitter Profile Photo

Developing useful, proven tools for rigorous assessment is something of a Department of Population Medicine specialty. Read on to learn how a team led by Christine Lu created a flexible, scalable tool to assess the impact of FDA regulatory actions on drug use: buff.ly/3FYNFbc International Society for Pharmacoepidemiology

Developing useful, proven tools for rigorous assessment is something of a <a href="/DeptPopMed/">Department of Population Medicine</a> specialty. 

Read on to learn how a team led by <a href="/ChrisLuPhD/">Christine Lu</a> created a flexible, scalable tool to assess the impact of FDA regulatory actions on drug use: buff.ly/3FYNFbc <a href="/IntPharmacoEpi/">International Society for Pharmacoepidemiology</a>
Division of Health Policy and Insurance Research (@healthpolicydpm) 's Twitter Profile Photo

Happy #ResearchWednesday! Check out an article by #HPI's #FangZhang and Christine Lu that assesses how privacy-related experiences may shape participants' willingness to share data with researchers. Read it here: mdpi.com/2075-4426/12/1…

Happy #ResearchWednesday! Check out an article by #HPI's #FangZhang and <a href="/ChrisLuPhD/">Christine Lu</a> that assesses how privacy-related experiences may shape participants' willingness to share data with researchers. Read it here: mdpi.com/2075-4426/12/1…
PROMoTeR_DPM (@promoter_dpm) 's Twitter Profile Photo

New Article! " #Physicians’ #Knowledge, #Attitude, and #Experience of #Pharmacogenomic #Testing in China" Co authored by PROMoTeR_DPM Member, Christine Lu buff.ly/3judW7S

New Article! " #Physicians’ #Knowledge, #Attitude, and #Experience of #Pharmacogenomic #Testing in China" Co authored by <a href="/PROMoTeR_DPM/">PROMoTeR_DPM</a> Member, <a href="/ChrisLuPhD/">Christine Lu</a> buff.ly/3judW7S
Department of Population Medicine (@deptpopmed) 's Twitter Profile Photo

Using precision #oncology as an example, Department of Population Medicine's Christine Lu & colleagues propose an alternative, integrated model in which governments and industry share the risks and benefits of drug development. Online now in npj Journals #PrecisionOncology buff.ly/3jaD3wF

Using precision #oncology as an example, <a href="/DeptPopMed/">Department of Population Medicine</a>'s <a href="/ChrisLuPhD/">Christine Lu</a> &amp; colleagues propose an alternative, integrated model in which governments and industry share the risks and benefits of drug development. 

Online now in <a href="/Nature_NPJ/">npj Journals</a> #PrecisionOncology buff.ly/3jaD3wF
Professor DM Thomas (@profdmthomas) 's Twitter Profile Photo

Next week we hold a podcast discussing a model for more affordable science-led health care. If this is important to you, please read: doi.org/10.1038/s41698… Register for free or find out more: lnkd.in/gBgdjuxg

Omico Australia (@omicoaustralia) 's Twitter Profile Photo

🔜 Don’t miss out on tomorrow’s ‘Precision Medicine: Affording the Successes of Science’ #webinar with Professor DM Thomas & Vera Terry. If you’re passionate about advancing #PrecisionMedicine, this one’s for you. Register here: us02web.zoom.us/webinar/regist…

Genomes2People (@genomes2people) 's Twitter Profile Photo

Pharmacogenomic clinical decision support (CDS) alerts for statin therapy is an effective strategy to mitigate adverse effects such as statin-associated muscle symptoms. Structured options within CDS alerts influence provider ordering behavior. Read: bit.ly/3p6w5vO

Pharmacogenomic clinical decision support (CDS) alerts for statin therapy is an effective strategy to mitigate adverse effects such as statin-associated muscle symptoms. Structured options within CDS alerts influence provider ordering behavior. 

Read: bit.ly/3p6w5vO
Department of Population Medicine (@deptpopmed) 's Twitter Profile Photo

A new publication led by former @HealthPolicy_DPM fellow alison mcclean w/ Department of Population Medicine's #AnitaWagner & Christine Lu suggests that, while #biosimilar use is on the rise, the cost savings in #Medicare Part B remain unrealized. Read more in JCO Oncology Practice: buff.ly/3EJfamX

A new publication led by former @HealthPolicy_DPM fellow <a href="/alison_mcclean/">alison mcclean</a> w/ <a href="/DeptPopMed/">Department of Population Medicine</a>'s #AnitaWagner &amp; <a href="/ChrisLuPhD/">Christine Lu</a> suggests that, while #biosimilar use is on the rise, the cost savings in #Medicare Part B remain unrealized. 

Read more in <a href="/JCOOP_ASCO/">JCO Oncology Practice</a>: buff.ly/3EJfamX
Australian Academy of Health and Medical Sciences (@aahms_health) 's Twitter Profile Photo

“I look forward to working with an external mentor who is a senior researcher & leader in the sector & who would be able to provide strategic advice & holistic perspectives for career development & leadership.” Prof Christine Lu Christine Lu, University of Sydney Sydney Health Kolling Institute

“I look forward to working with an external mentor who is a senior researcher &amp; leader in the sector &amp; who would be able to provide strategic advice &amp; holistic perspectives for career development &amp; leadership.” Prof Christine Lu <a href="/ChrisLuPhD/">Christine Lu</a>, <a href="/Sydney_Uni/">University of Sydney</a> <a href="/syd_health/">Sydney Health</a>  <a href="/KollingINST/">Kolling Institute</a>
Division of Health Policy and Insurance Research (@healthpolicydpm) 's Twitter Profile Photo

#HarvardMedicalSchool & #HPI researcher, Stephen Soumerai, alongside #UPenn, #USydney, #NortheasternU, and #LSE researchers found large reductions in pediatric mental health care following 2003 FDA Black Box Warnings. Read the article here: bit.ly/3Y1PbSm

#HarvardMedicalSchool &amp; #HPI researcher, <a href="/StephenSoumerai/">Stephen Soumerai</a>, alongside #UPenn, #USydney,  #NortheasternU, and #LSE researchers found large reductions in pediatric mental health care following 2003 FDA Black Box Warnings. Read the article here: bit.ly/3Y1PbSm
Health Affairs (@health_affairs) 's Twitter Profile Photo

Stephen Soumerai of Harvard Medical School et al, examined the adverse effects of FDA-issued black-box warnings on child and adolescent mental health outcomes such as reduced depression diagnosis and increased suicide rate. Read the full article here: bit.ly/4eZJGJr

Stephen Soumerai of <a href="/harvardmed/">Harvard Medical School</a> et al, examined the adverse effects of FDA-issued black-box warnings on child and adolescent mental health outcomes such as reduced depression diagnosis and increased suicide rate. Read the full article here: bit.ly/4eZJGJr